-

Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners

International competition rewards top proteomics researchers for outstanding innovation and societal impact

SAN JOSE, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, announces the winners of the 2022 Thermo Scientific Tandem Mass Tag (TMT) Research Award. Now in its eighth year, the research competition selects scientists from a pool of international applicants based on innovation and the potential impact of their work in proteomics using TMT. The proprietary TMT and TMTpro reagents are exclusively licensed to Thermo Fisher Scientific by Proteome Sciences, PLC.

Winners receive awards of TMT and other mass spectrometry-related reagents, valued at US$11,000. The scientists will use these awards to quantify, normalize and streamline global protein expression studies using mass spectrometry.

A panel of judges from Thermo Fisher and Proteome Sciences, PLC, reviewed the applications and selected the following two recipients based on the scientific merit of their proposals:

  • Stephen Holmes, University of Liverpool
    Grant Title: Inactivating and studying viruses at single-cell level
  • Dick Zijlmans, Stichting Radboud Universiteit
    Grant Title: Identifying true interactors in proximal proteome through target protein perturbation

“We are excited to offer the TMT Research Grant Award for the eighth consecutive year,” said Nicolas Pierre, senior director/general manager, cell & protein consumables, life sciences and laboratory products, Thermo Fisher Scientific. “We received a wide range of diverse submissions from graduate and postdoctoral students. We look forward to seeing what these emerging scientists achieve with our reagents and are eager to get a glimpse from them into the future of multiplex proteomics.”

Thermo Fisher Scientific is showcasing the grant award winners during the 70th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, being held June 5-9, 2022 in Booth 400 at the Minneapolis Convention Center, Minneapolis, Minnesota and at the Hilton Minneapolis Grand Ballrooms E, F, G.

For more information, visit http://www.thermofisher.com/tmtgrant.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Laura Bright
Thermo Fisher Scientific
+1 562-335-8318
laura.bright@thermofisher.com

Janice Foley
BioStrata
+1 617-823-5555
jfoley@biostratamarketing.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Summary
Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Awards to top proteomics researchers for outstanding innovation and societal impact.
Release Versions

Contacts

Laura Bright
Thermo Fisher Scientific
+1 562-335-8318
laura.bright@thermofisher.com

Janice Foley
BioStrata
+1 617-823-5555
jfoley@biostratamarketing.com

More News From Thermo Fisher

Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the global launch of the Gibco™ CTS™ Compleo™ Fill and Finish System, an automated, functionally closed solution designed to streamline formulation and filling in cell therapy manufacturing. Because cell therapies often begin with patient-derived cells, manufacturing workflows must accommodate variability in cell count, concentration and viability. As more therapies move toward c...

Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability. Global pipelines for protein therapeutics, including complex biologics and biosimilars used to treat conditions ranging from cancer to autoimmune and rare diseases, continue to expand. This...

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2026 before the market opens on Thursday, April 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our website, www.thermofish...
Back to Newsroom